Infectious Diseases News and Research

RSS

Intercell reports EUR 4.8m revenue, EUR 14.7m net loss for first-quarter 2010

Today, the biotech-vaccine company Intercell AG announced its financial results for Q1 and presented an update on the Company's development programs.

11 May 2010

New York Times examines global fight against HIV/AIDS

Several articles in the New York Times examine the global fight against HIV/AIDS. "Uganda is the first country where major clinics routinely turn people away" because they lack funding, the newspaper writes in an article that reports "money for [HIV/AIDS] treatment has stopped growing."

11 May 2010

Achillion reports lower net loss of $5.6M for first-quarter 2010

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three months ended March 31, 2010. For the first quarter of 2010, the Company reported a net loss of $5.6 million or $0.16 per share, compared with a net loss of $6.7 million or $0.25 per share for the first quarter of 2009. Cash, cash equivalents and marketable securities as of March 31, 2010 were $25.0 million, up $15.3 million compared with December 31, 2009.

10 May 2010

Creator of California Tay-Sachs Disease Prevention Program among the honorees

A mere 40 years ago, parents didn't know they were carriers of the Tay-Sachs disease until after they'd given birth to a child with this fatal genetic disorder.

7 May 2010

Encouraging B. anthracis to unwittingly unmask itself will help eradicate the pathogen

Anthrax-causing bacteria can be engineered to shed their invisibility cloaks, making it easier for the immune system to eradicate it, according to a new study published in Microbiology. The work could lead to new measures to treat anthrax infection in the event of a biological warfare attack.

7 May 2010

ETH Zurich researchers discover HIV transmission chains

Since the emergence of the first AIDS cases in the early 1980s, an infectious wave has spread over Switzerland. Every year, several hundred people are infected with the HI-virus which triggers the acquired immunodeficiency syndrome, AIDS. Does the infection spread according to a particular pattern? Do these patterns vary among the transmission groups such as drug addicts, homosexual or heterosexual persons?

7 May 2010

New CD4 test kit can improve quality of life for HIV and AIDS patients

The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.

7 May 2010

Genzyme to initiate $2 billion stock buyback

Genzyme Corp. today announced that its Board of Directors has voted to pursue several actions to increase shareholder value. The company will initiate a $2 billion stock buyback, under which $1 billion of stock will be repurchased in the near term and financed with debt. The additional $1 billion of stock will be repurchased during the next 12 months.

7 May 2010

Darwin may have lost his own children due to ill effects of inbreeding

Charles Darwin whose theories on evolution have been the basis of all that we know about the evolution of mankind and genetics may have lost his own progeny to inbreeding says a new study.

6 May 2010

Researchers demonstrate how Plasmodium falciparum can able to circumvent action of artemisinin

Researchers from CNRS, INSERM and Toulouse University Hospital have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the first-line drugs used to treat this disease. This study supplies some important findings that will enable a clearer understanding of the mechanisms of resistance to antimalarial drugs and the testing of novel therapeutic strategies in a context where the drug resistance of parasites is of increasing concern.

6 May 2010

Experts unveil roadmap to improve health and health delivery in the U.S.

A Commission of national health care experts convened by the Center for the Study of the Presidency and Congress has unveiled a roadmap and integrated approach that will put "health" back into our nation's health care system as well as address key opportunities following passage of health care reform legislation.

6 May 2010

Nanosphere reports $0.8 million revenue for first-quarter 2010

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

Intercell AG today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos' platform technology for monoclonal antibody discovery. The technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases.

6 May 2010

Annual heart disease and stroke rates in China to rise up to 73% by 2030: Research

Annual heart disease and stroke rates in China will rise by up to 73 percent by 2030, given an aging population and other increased risk factors, without policies and prevention efforts aimed at controlling blood pressure and smoking, according to research from Columbia University Medical Center published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

6 May 2010

New breakthrough: Seaweed for treatment of swine flu

In a groundbreaking new discovery a Tasmanian company has used seaweed as treatment for swine flu. The lab trials have been going on for the past nine months using the undaria seaweed (better know as wakame seaweed) harvested from waters at Triabunna, of Tasmania's East Coast.

5 May 2010

Vical commences enrollment in Phase 1 trial of Vaxfectin DNA pandemic influenza vaccine

Vical Incorporated today announced the enrollment of the first subject in its Phase 1 trial of the company's Vaxfectin®-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The trial will be conducted in collaboration with the U.S. Naval Medical Research Center (NMRC).

5 May 2010

Calgary doctors research how to minimize complications from Cryptococcus disease

Cryptococcus disease is a rare but serious infection resulting from inhaling a toxic fungus often found in fir trees. Approximately 250 people have been infected with the disease in British Columbia since its emergence in 1999. The disease can cause meningitis, pneumonia and in 10 per cent of cases it can lead to death.

5 May 2010

New findings show seaweed extract inhibits H1N1 virus

In a breakthrough that offers new hope for the containment of influenza outbreaks, an Australian biotechnology company has isolated a natural extract from seaweed which has been shown to inhibit the H1N1 virus.

5 May 2010

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors, today reported financial results for the first quarter ended March 31, 2010.

5 May 2010

Second fidaxomicin Phase 3 clinical study data in patients with CDI to be presented at DDW 2010

Optimer Pharmaceuticals, Inc. announced the presentation of new data from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection. The data, presented by Stuart Johnson, M.D. during an oral session at the annual meeting of Digestive Disease Week in New Orleans, indicated that treatment with fidaxomicin significantly improved the recurrence rate and global cure rate in CDI patients requiring concomitant antibiotics, compared to vancomycin.

5 May 2010

Infectious Diseases News and Research

Intercell reports EUR 4.8m revenue, EUR 14.7m net loss for first-quarter 2010

New York Times examines global fight against HIV/AIDS

Achillion reports lower net loss of $5.6M for first-quarter 2010

Creator of California Tay-Sachs Disease Prevention Program among the honorees

Encouraging B. anthracis to unwittingly unmask itself will help eradicate the pathogen

ETH Zurich researchers discover HIV transmission chains

New CD4 test kit can improve quality of life for HIV and AIDS patients

Genzyme to initiate $2 billion stock buyback

Darwin may have lost his own children due to ill effects of inbreeding

Researchers demonstrate how Plasmodium falciparum can able to circumvent action of artemisinin

Experts unveil roadmap to improve health and health delivery in the U.S.

Nanosphere reports $0.8 million revenue for first-quarter 2010

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

Annual heart disease and stroke rates in China to rise up to 73% by 2030: Research

New breakthrough: Seaweed for treatment of swine flu

Vical commences enrollment in Phase 1 trial of Vaxfectin DNA pandemic influenza vaccine

Calgary doctors research how to minimize complications from Cryptococcus disease

New findings show seaweed extract inhibits H1N1 virus

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Second fidaxomicin Phase 3 clinical study data in patients with CDI to be presented at DDW 2010

NGS for Infectious Disease Surveillance eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News